Navigation Links
Kogenate® FS, Antihemophilic Factor (Recombinant), for Hemophilia A Now Easier For People to Store at Home or On The Go
Date:4/25/2011

WAYNE, N.J., April 25, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved a new storage option for Kogenate® FS, antihemophilic factor (recombinant), now allowing the product to be stored at room temperature (up to 77 degrees F) for up to one year.  Compared with the previous three-month room temperature option, this new storage option for Kogenate FS offers added convenience for patients with hemophilia A and is immediately available to customers.

Factor VIII products are typically stored in the refrigerator and are stable at room temperature for a limited time.  With this new storage option, people who use Kogenate FS may have more flexibility for storing their medication whether they're at home or at school, at work or at play or when traveling. For some, the approval of this new storage option may free up refrigerator space or possibly eliminate the need for a separate "factor fridge."  

"As convenience with medication is important to people with hemophilia A, we're pleased to offer a new storage temperature option, which complements other convenience features, including Grab and Go packaging with BIO-SET®, a compact and complete reconstitution system for Kogenate FS," said Paul Bedard, Vice President/General Manager, Hematology, Bayer HealthCare Pharmaceuticals.  "This new option demonstrates Bayer's ongoing commitment to the hemophilia A community."

The starting date of room temperature storage for Kogenate FS should be clearly recorded on the unopened product carton.  Once stored at room temperature, the product must not be returned to the refrigerator.  The shelf-life then expires after the storage at room temperature (up to 12 months) or the expiration date on the product vial, whichever is earlier.

For additional information on Kogenate® FS, and the new and extended storage capabilities,
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Daiichi Sankyo Receives First Market Approval in Japan for LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
2. NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
3. Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval
4. Success Factors and Failure Points in Biopharmaceutical Product Launches
5. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
6. Inspiration Biopharmaceuticals Demonstrates Non-Inferiority of IB1001, Its Recombinant Factor IX for Hemophilia B
7. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
8. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
9. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
10. Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process
11. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... and BOSTON , January 23, ... drug discovery and development company, is delighted to announce that ... been awarded to Miles Congreve (Vice President of ... and Malcolm Weir (Chief Executive Officer and co-founder) ...
(Date:1/22/2015)... BOULDER, Colo. , Jan. 22, 2015  BiOptix is ... Klakamp as Vice President of Chemistry and Biochemistry. Scott ... Takeda Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course ... and development. "Scott is a nationally recognized ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Aug. 16, 2011 Practice Fusion,s Research Division ... the 20 most commonly prescribed medications by specialty ... (EMR) system. Topping the list are prescriptions for ... (Simvastatin, Internal Medicine ), infection (Amoxicillin, ...
... Edwards, Inc. (Nasdaq: MSHL ), an oncology ... targeting cancer metabolism, announced today that its Investigational New ... lead NADH oxidase inhibitor, has been approved by the ... to initiate a Phase I clinical trial of intravenous ...
Cached Medicine Technology:2011 Prescription Index from the Practice Fusion Research Division 22011 Prescription Index from the Practice Fusion Research Division 32011 Prescription Index from the Practice Fusion Research Division 4Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143 2Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 Liberty University has ... (M.A.) program from the Council for Accreditation of ... part of Liberty’s Center for Counseling & Family Studies ... dean of the university’s new School of Behavioral Sciences. Prior ...
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... A year after hospital discharge, the majority of ... comes to taking their prescribed secondary stroke prevention medications, ... shows. However, there is room for improvement, according to ... factor for stroke and heart disease, and we know ...
... Once a cancer gains the ability to invade local ... harder to treat. A team of researchers, led by Min ... Nashville, has now identified the protein BVES as a suppressor ... to suggest that BVES could be a therapeutic or preventative ...
... published in The Journal of Sexual Medicine reveals that ... or clitoris was shown to activate three separate and ... have claimed that the major source of genital sensation ... by vaginal or cervical stimulation., Researchers led by Barry ...
... HealthDay Reporter , SUNDAY, Sept. 11 (HealthDay News) ... bombing of Pearl Harbor still packs a psychological punch for ... it serves as the moment when a stunned young country ... world stage with the now-iconic can-do bravado of the "Greatest ...
... be used to avoid hazardous waste being dumped where ... countries? Introducing producer responsibility could be one solution, says ... Economics (IIIEE) at Lund University, Sweden, in a new ... electrical and electronic equipment (WEEE) in China, India and ...
... , MONDAY, Sept. 12 (HealthDay News) -- Linking doctors, ... number of patients who follow doctor,s orders on medications ... The research included more than 12,00 men and women ... or cholesterol medications over a period of 18 months. ...
Cached Medicine News:Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 2Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 3Health News:Researchers focus on secondary stroke prevention after study reveals room for improvement 4Health News:JCI online early table of contents: Sept. 12, 2011 2Health News:JCI online early table of contents: Sept. 12, 2011 3Health News:JCI online early table of contents: Sept. 12, 2011 4Health News:JCI online early table of contents: Sept. 12, 2011 5Health News:JCI online early table of contents: Sept. 12, 2011 6Health News:JCI online early table of contents: Sept. 12, 2011 7Health News:JCI online early table of contents: Sept. 12, 2011 8Health News:Stimulation of female genital regions produces strong activation of various brain sites 2Health News:9/11 Left Permanent Scars on the American Psyche 2Health News:9/11 Left Permanent Scars on the American Psyche 3Health News:9/11 Left Permanent Scars on the American Psyche 4Health News:9/11 Left Permanent Scars on the American Psyche 5Health News:9/11 Left Permanent Scars on the American Psyche 6Health News:Producer responsibility solution to electronic waste in developing countries 2Health News:Producer responsibility solution to electronic waste in developing countries 3Health News:Linking Pharmacies With Doctors' Offices Can Improve Med Adherence: Study 2
... semi-automated agarose gel electrophoresis system is ... steps involved in classic electrophoresis and ... out all phases of electrophoresis ... incubation to staining, destaining and drying. ...
Handheld Digital Retinal Camera...
Inquire...
Millennium Forceps designed specifically for graft insertion....
Medicine Products: